Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-07-21
1994-03-01
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142315, 514252, 514278, 514397, 514409, A61K 31335
Patent
active
052908070
ABSTRACT:
O-substituted fumagillol derivatives and its salts have an angiogenesis regressing activity are useful for treatment of diseases induced by abnormally stimulated neovascularization.
REFERENCES:
patent: 4954496 (1990-09-01), Oku et al.
Chemical Abstracts, vol. 70, No. 9, Mar. 3, 1969, p. 206, Abstract No. 36365g, Columbus, Ohio, US; M. M. Maevskii et al.
Chemical Abstracts, vol. 106, No. 21, May 25, 1987, p. 706, Abstract No. 176153y, Columbus, Ohio, US; JP-A-62 00 476 (Fujisawa Pharmaceutical Co., Ltd.).
Derwent Printout from Dialog of the abstract corresponding to Japanese Kokai Tokkyo Koho No. 58-131978 (1983).
Derwent Printout frm Dialog of the abstract corresponding to Japanese Kokai Tokkyo Koho No. 63-119500 (1988).
S. Taylor, et al., Nature, 297:307 (1982).
J. Folkman et al., Science, 221:719 (1983).
D. Tarbell, et al., J. Am. Chem. Soc. 83:3096 (1961).
O. Mitunobu, Synthesis (1981), 1, pp. 1-28.
I. Sutherland (Ed.), "Compreshensive Organic Chemistry", vol. 2, pp. 4-11, Pergamon Press (1979).
Gimbrone, et al., J. National Cancer Institute, 52:413-419 (1974).
J. Ross, et al., J. Am. Chem. Soc., 78:4675 (1956).
Falk, et al., J. Immunol. Meth., 33:239-247 (1980).
Folkman, et al., Science, 230:1375 (1985).
Chemical Patent Index, Basic Abstracts Journal Section B, Week 8706, Abstract No. 87-040948/06. Abstract of JP-A-476/1987.
J. DiPaolo, et al., Antibiotics Annual, 1958-1959, pp. 541-546.
G. Ruecker, et al., Chemical Abstracts, 77:29f (1972).
The Merck Index, 11th Ed., (1989) pp. 670-671; Compound No. 4199-Fumagillin.
Folkman Moses J.
Ingber Donald
Children's Medical Center Corporation
Conlin David G.
Datlow Philip I.
Ford John M.
Resnick David S.
LandOfFree
Method for regressing angiogenesis using o-substituted fumagillo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for regressing angiogenesis using o-substituted fumagillo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for regressing angiogenesis using o-substituted fumagillo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-577509